secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-07-29T23:59:59+00:00
Accession:  0001493152-24-029384
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics raises $3M from Dr. Ronald Rigor; launches Nova Cell subsidiary with $2M investment
--------------------------------------------------------------------------------

- Dr. Ronald Rigor invests $1M in Calidi via 698,812 shares at $1.431 and warrants for 600,000 shares at $1.90.
- Dr. Rigor invests $2M in Nova Cell subsidiary for 25% fully-diluted equity; IP assigned to Nova Cell.
- Dr. Rigor appointed to Scientific and Medical Advisory Board; receives 5,000 stock options.
- Exclusive license for Philippines for AAA stem cells and CLD-201; initial revenue expected 2025.
- Nova Cell to focus on regenerative medicine, cosmetics, orthopedics; Calidi retains oncology focus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224029384/0001493152-24-029384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224029384/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-029384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer